After transfection, the Opti-MEM medium was replaced using the corresponding supplemented medium. Kv10.1 were also more private to mitochondrial fat […]
Targeting FLT3 for Cancer therapy
FLT3 inhibitors
After transfection, the Opti-MEM medium was replaced using the corresponding supplemented medium. Kv10.1 were also more private to mitochondrial fat […]